Ligand validation:7B8C

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7B8C_NAG_A_502	18%	81%	0.202	0.785	0.26	0.55	-	-	0	0	100%	1
4UZ6_NAG_A_1452	59%	39%	0.096	0.876	0.88	1.5	1	3	0	0	100%	1
7BNE_NAG_A_504	47%	88%	0.141	0.879	0.26	0.41	-	-	0	0	100%	1
4UYU_NAG_B_1452	38%	51%	0.129	0.829	0.72	1.15	-	2	0	0	100%	1
6R8Q_NAG_A_501	35%	89%	0.161	0.85	0.2	0.43	-	-	0	0	100%	1
7BNC_NAG_A_609	34%	79%	0.165	0.849	0.25	0.6	-	-	0	0	100%	1
4GEZ_NAG_C_502	100%	57%	0.027	0.988	0.6	1.03	-	1	1	0	100%	1
3K39_NAG_L_900	100%	32%	0.032	0.989	0.59	2.07	-	4	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	1
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	1
4M44_NAG_A_403	100%	75%	0.035	0.989	0.46	0.53	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.